Guess I didn't think of that. It is obvious to me that if Management of FDMF did so it would be insider trading but I am not certain if that would be true of BP. Could very well be.
While KC9000 is an obvious solution, I wouldn't expect BP to take notice of any small cap products when in fact they can't even review what is already at their doorstep.
I could see BP taking first right of refusal on all of FDMC's product. Which isn't a bad idea by itself. Why sell the goose?
There is no regulation that I am aware of that either restricts insider buying of it's own stock on the open market nor is there a requirement to file their purchases since Pink Sheet stocks are not regulated.